Decheng Capital LLC Equillium, Inc. Transaction History
Decheng Capital LLC
- $326 Billion
- Q2 2024
A detailed history of Decheng Capital LLC transactions in Equillium, Inc. stock. As of the latest transaction made, Decheng Capital LLC holds 4,447,308 shares of EQ stock, worth $6.09 Million. This represents 0.94% of its overall portfolio holdings.
Number of Shares
4,447,308
Previous 4,447,308
-0.0%
Holding current value
$6.09 Million
Previous $10.3 Billion
69.99%
% of portfolio
0.94%
Previous 1.38%
Shares
1 transactions
Others Institutions Holding EQ
# of Institutions
27Shares Held
11.5MCall Options Held
38.1KPut Options Held
0-
Decheng Capital Management Iii (Cayman), LLC4.45MShares$6.09 Million1.82% of portfolio
-
Vanguard Group Inc Valley Forge, PA842KShares$1.15 Million0.0% of portfolio
-
Cota Capital Management, LLC San Francisco, CA562KShares$770,3201.37% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny300KShares$411,5480.0% of portfolio
-
Geode Capital Management, LLC Boston, MA216KShares$296,1990.0% of portfolio
About Equillium, Inc.
- Ticker EQ
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 34,352,100
- Market Cap $47.1M
- Description
- Equillium, Inc., a clinical-stage biotechnology company, develops and sells products to treat severe autoimmune and inflammatory, or immuno-inflammatory disorders with unmet medical need. The company's lead product candidate is itolizumab (EQ001), a clinical-stage monoclonal antibody that targets the novel immune checkpoint receptor CD6, which i...